Table 2 FDG PET/CT Positron Emission Tomography – Computed Tomography Findings
Characterization on FDG PET/CT | N (%) |
|---|---|
Benign | 38 (50.6%) |
Malignant | 31 (41.3%) |
Intermediate | 6 (8%) |
Hilar and Mediastinal lymphadenopathy | 12 (16%) |
Average size of benign nodule (size± SD) | 13.7 (±10.5) mm |
Average size of malignant nodule (size ± SD) | 20.8 (±9.9) mm |
Location of dominant/ largest nodule | |
Right upper lobe | 23 (30.6%) |
Right middle lobe | 6 (8%) |
Right lower lobe | 18 (24%) |
Left upper lobe | 18 (24%) |
Left lower lobe | 9 (12%) |
No dominant nodule | 1 (1.3%) |